Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy

Purpose The aim of this study is to examine and compare with the validated, paper/pencil European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy Scale (QLQ-CIPN20), the psychometric properties of three electronically adminis...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2017-11, Vol.25 (11), p.3437-3446
Main Authors: Knoerl, Robert, Gray, Evan, Stricker, Carrie, Mitchell, Sandra A., Kippe, Kelsey, Smith, Gloria, Dudley, William N., Lavoie Smith, Ellen M.
Format: Article
Language:English
Subjects:
Analysis
Antineoplastic Agents - adverse effects
Breast cancer
Cancer
Cancer research
Care and treatment
Chemotherapy
Cross-Sectional Studies
Diagnosis
Electronics
Female
Humans
Male
Medicine
Medicine & Public Health
Methods
Neoplasms - drug therapy
Nursing
Nursing Research
Oncology
Original Article
Pain Medicine
Patient Reported Outcome Measures
Peripheral Nervous System Diseases - chemically induced
Peripheral neuropathy
Quality of life
Quality of Life - psychology
Questionnaires
Rehabilitation Medicine
Reproducibility of Results
Terminology
Validation studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The aim of this study is to examine and compare with the validated, paper/pencil European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy Scale (QLQ-CIPN20), the psychometric properties of three electronically administered patient reported outcome (PRO) measures of chemotherapy-induced peripheral neuropathy (CIPN): (1) the two neuropathy items from the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), (2) the QLQ-CIPN20, and (3) the 0–10 Neuropathy Screening Question (NSQ). Methods We employed a descriptive, cross-sectional design and recruited 25 women with breast cancer who were receiving neurotoxic chemotherapy at an academic hospital. Participants completed the paper/pencil QLQ-CIPN20 and electronic versions of the QLQ-CIPN20, PRO-CTCAE, and NSQ. Internal consistency reliability, intraclass correlation, and concurrent and discriminant validity analyses were conducted. Results The alpha coefficients for the electronic QLQ-CIPN20 sensory and motor subscales were 0.76 and 0.75. Comparison of the electronic and paper/pencil QLQ-CIPN20 subscales supported mode equivalence (intraclass correlation range >0.91). Participants who reported the presence of numbness/tingling via the single-item NSQ reported higher mean QLQ-CIPN20 sensory subscale scores ( p  
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-017-3764-y